BabakEdrakiMD

Obstetrics & Gynecology • Walnut Creek, CA

Critical Care Medicine, General Gynecology, Gynecologic Oncology

Physician

Join to view full profile

Are you Dr. Edraki?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 63 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
1479 Ygnacio Valley Rd
Walnut Creek, CA 94598
Phone+1 925-627-3440

Fax+1 925-627-3450

Summary

Dr. Babak Edraki, MD is an obstetrician/gynecologist in Walnut Creek, California. He is currently licensed to practice medicine in California, New Jersey, and Texas. He is affiliated with John Muir Medical Center, Walnut Creek, John Muir Medical Center, Concord, and San Ramon Regional Medical Center.

Education & Training

Stanford Health Care-Sponsored Stanford UniversityResidency, Obstetrics and Gynecology, 1989 - 1992
Santa Clara Valley Medical CenterInternship, Transitional Year, 1988 - 1989
George Washington University School of Medicine and Health SciencesClass of 1988

Certifications & Licensure

CA State Medical License 1989 - 2026
NJ State Medical License 1997 - 1999
TX State Medical License 1996 - 1998
CT State Medical License 1994 - 1996
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
Recruiting
Phase 3
Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Dec 13
Completed
Phase 2
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
Active, not recruiting
Phase 3
Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer Start of enrollment: 2011 Jun 01
Completed
Phase 2
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

158 citations
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition
Siming Zhao, Stefania Bellone, Salvatore Lopez, Durga Thakral, Carlton L. Schwab
Proceedings of the National Academy of Sciences of the United States of America. 2016-10-25
273 citations
Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Fact...
Amanda N. Fader, Dana M. Roque, Eric R. Siegel, Natalia Buza, Pei Hui
Journal of Clinical Oncology. 2018-03-27
127 citations
Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas ...
Amanda N. Fader, Dana M. Roque, Eric R. Siegel, Natalia Buza, Pei Hui
Clinical Cancer Research. 2020-08-01

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow